Article Text

PDF

Acute disseminated encephalomyelitis
  1. R K Garg
  1. Department of Neurology, King George’s Medical College, Lucknow, India
  1. Correspondence to:
 Dr R K Garg, Department of Neurology, King George’s Medical College, Lucknow 226003, India;
 garg50{at}yahoo.com

Abstract

Acute disseminated encephalomyelitis (ADEM) is an acute demyelinating disorder of the central nervous system, and is characterised by multifocal white matter involvement. Diffuse neurological signs along with multifocal lesions in brain and spinal cord characterise the disease. Possibly, a T cell mediated autoimmune response to myelin basic protein, triggered by an infection or vaccination, underlies its pathogenesis. ADEM is a monophasic illness with favourable long term prognosis. The differentiation of ADEM from a first attack of multiple sclerosis has prognostic and therapeutic implications; this distinction is often difficult. Most patients with ADEM improve with methylprednisolone. If that fails immunoglobulins, plasmapheresis, or cytotoxic drugs can be given. Recent literature suggests that a significant proportion of patients with ADEM will later develop multiple sclerosis; however, follow up experience from developing countries does not support this view.

  • encephalopathy
  • demyelination
  • methylprednisolone
  • multiple sclerosis
  • neuromyelitis optica
  • parainfectious diseases
  • ADEM, acute disseminated encephalomyelitis
  • EAE, experimental allergic encephalomyelitis
  • FLAIR, fluid attenuated inversion recovery sequence
  • HEAE, hyperacute experimental allergic encephalomyelitis
  • MHC, major histocompatibility complex
  • MRI, magnetic resonance imaging

Statistics from Altmetric.com

Footnotes

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.